News
PI, a global leader in piezo nanopositioning and precision motion control equipment, announces the S-312 piezo phase shifter ...
New SBIR Phase III Catalog Advances the Procurement Process The catalog puts mission-ready commercial technologies all in one place for government buyers.
The Phase 3 VERIFY study (NCT05210790) is an ongoing, three-part, global, randomized, placebo-controlled study evaluating rusfertide in 293 patients with polycythemia vera over a 156-week period.
REJOICE-PanTumor01: A phase 2 signal-seeking study of raludotatug deruxtecan (R-DXd) in patients with advanced or metastatic gynecologic or genitourinary tumors.
References: Viatris announces positive results from phase 3 study of investigational Xulane Lo™ low dose patch for birth control in women of childbearing potential. News release. Viatris.
Google faces a crucial moment with the DOJ's remedy hearing. The DOJ has asked for Chrome and Android's separation due to antitrust violations.
A new phase begins in Trump's battle with higher education Harvard pushed back hard this week on the White House's efforts to influence its campus. Its defiance seemed to give permission to other ...
The Trump administration is gutting agencies, systematically firing scientists and health workers without cause and dispensing with thousands of years of collective knowledge and expertise.
Fourteen signalized intersections in Murfreesboro will receive high-tech improvements in order to help the flow of traffic in a highly traveled area.
Israel to send delegation to Doha on Monday for ceasefire talks Hamas sees positive signs for second-phase ceasefire negotiations Israeli airstrike kills two Palestinians in Rafah, medical sources say ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results